The U.S. Food and Drug Administration (FDA) has ordered a recall of Rosabella-brand moringa powder capsules after an investigation linked the product to a multistate outbreak of Salmonella Newport infections. The agency is advising consumers and retailers to discard or return the supplements issued by Ambrosia Brands LLC, citing concerns over antibiotic-resistant bacteria contamination.
Salmonella Outbreak Details
The Centers for Disease Control and Prevention (CDC) reported seven confirmed cases of Salmonella Newport infections across seven states, including Washington, Arizona, Iowa, Illinois, Indiana, Tennessee, and Florida. These cases have occurred between November 7, 2025, and January 8 of this year. Among those infected, three individuals required hospitalization, but no fatalities have been recorded.
Product Distribution and Recall Scope
The affected Rosabella supplements were distributed through various online platforms such as eBay, TikTok Shop, Amazon, Shein, and the brand’s official website Tryrosabella.com. The recall specifically targets products with expiration dates ranging from March 2027 to November 2027.
Health Risks and Warnings
Salmonella infection is a serious bacterial illness primarily targeting the intestinal tract, capable of causing symptoms like diarrhea, fever, and abdominal cramps. Alarmingly, the FDA has identified that the Salmonella strain involved in this outbreak shows high resistance to all common first-line and alternative antibiotics used against such infections, making the situation more critical.
Ongoing Investigation and Manufacturer Response
The FDA continues to collaborate with state health officials to track and pinpoint the contamination source. Ambrosia Brands LLC has voluntarily agreed to the recall and stated they have stopped all purchases of raw moringa powder from the suspect supplier. The company expressed regret for any inconvenience and concern this recall may cause consumers.